Epistem

Epistem

Epistem

An innovative biotechnology company providing specialised research services, developing novel therapeutics and point of care molecular diagnostics.
Raised
$3.6M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
£2,500,000
Post-IPO equity - 2016
Team Size
1–10
Employees
£2,500,000 Post-IPO equity
Insider Media Ltd

Epistem lines up £2.5m cornerstone investor

Stock markets